I
MiNK Therapeutics D
D
INKT
0.69200
USD
0.01
(1.32%)
Market Closed
Volume
29
EPS
-0
Div Yield
-
P/E
-2
Market Cap
27,368,583
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: MiNK Therapeutics
Sector: Healthcare
Industry: Biotechnology
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.